Ironwood Capital is a private equity firm in Connecticut that focuses on providing non-control growth capital to middle market businesses. Founded 1985 in Avon, Connecticut, United States by Carolyn Galiette, Hiran Embuldeniya, and Marc Reich, it invests in early stage ventures and seed rounds. Its portfolio companies include P2 Science, IsoPlexis, Payveris, American Residuals Group, Bush Industries, My Alarm Center, and Pharmaceutic Litho & Label. As of March 2020, Ironwood Capital has made 22 investments. Their most recent investment was on January 29, 2020, when P2 Science raised $12M. Ironwood Capital has had five exits, the most notable of which include Precipio Diagnostics, FitLinxx, and Bush Industries. Ironwood Capital has raised three funds, their latest being Ironwood Mezzanine Fund IV. This fund was announced on July 23, 2018 and raised a total of $424M.
A bio-renewable chemistry company developing and producing specialty chemicals using renewable feedstocks
IsoPlexis is a Branford, Connecticut-based healthcare company developing a cellular response analysis platform.
Documentaries, videos and podcasts